Stearyl palmitate a multi-target inhibitor against breast cancer: in-silico, in-vitro & in-vivo approach by Ravi, Lokesh, Kumar K, Ajith, Kumari G R, Shree, S, Harsha, Sam Raj, Jabin B., R, Likitha, Chinnaiyan, Prawin, K C, David Jonnes, J K, Megha, Sudhakara, Dhanush, Dar, Musaib Shafi, D M, Yashaswini, G, Sathvik

Get full text

25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations by Lavell, A.H.A, Schramade, A.E, Sikkens, J.J, van der Straten, K, van Dort, K.A, Slim, M.A, Appelman, B, van Vught, L.A, Vlaar, A.P.J, Kootstra, N.A, van Gils, M.J, Smulders, Y.M, de Jongh, R.T, Bomers, M.K

Get full text

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees by Van Coillie, Julie, Pongracz, Tamas, Rahmöller, Johann, Chen, Hung-Jen, Geyer, Chiara Elisabeth, van Vught, Lonneke A, Buhre, Jana Sophia, Šuštić, Tonći, van Osch, Thijs Luc Junior, Steenhuis, Maurice, Hoepel, Willianne, Wang, Wenjun, Lixenfeld, Anne Sophie, Nouta, Jan, Keijzer, Sofie, Linty, Federica, Visser, Remco, Larsen, Mads Delbo, Martin, Emily Lara, Künsting, Inga, Lehrian, Selina, von Kopylow, Vera, Kern, Carsten, Lunding, Hanna Bele, de Winther, Menno, van Mourik, Niels, Rispens, Theo, Graf, Tobias, Slim, Marleen Adriana, Minnaar, René Peter, Bomers, Marije Kristianne, Sikkens, Jonne Jochum, Vlaar, Alexander P.J, van der Schoot, C. Ellen, den Dunnen, Jeroen, Wuhrer, Manfred, Ehlers, Marc, Vidarsson, Gestur

Get full text

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination by Appelman, Brent, van der Straten, Karlijn, Lavell, A.H. Ayesha, Schinkel, Michiel, Slim, Marleen A, Poniman, Meliawati, Burger, Judith A, Oomen, Melissa, Tejjani, Khadija, Vlaar, Alexander P.J, Wiersinga, W. Joost, Smulders, Yvo M, van Vught, Lonneke A, Sanders, Rogier W, van Gils, Marit J, Bomers, Marije K, Sikkens, Jonne J

Get full text